GRP
RXRX icon

Global Retirement Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

Global Retirement Partners’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257K Buy
+70,100
New +$233K ﹤0.01% 1422
2025
Q4 		$213K Buy
52,088
+1,543
+3% +$7.64K ﹤0.01% 1438
2025
Q3 		$247K Buy
50,545
+19,748
+64% +$104K 0.01% 1072
2025
Q2 		$156K Buy
+30,797
New +$151K ﹤0.01% 1213
2024
Q4 		$212K Buy
31,297
+7,500
+32% +$50.4K 0.01% 925
2024
Q3 		$157K Buy
23,797
+8,750
+58% +$62.7K ﹤0.01% 1019
2024
Q2 		$113K Buy
15,047
+13,547
+903% +$118K ﹤0.01% 1126
2024
Q1 		$15K Buy
1,500
+1,200
+400% +$13.4K ﹤0.01% 1936
2023
Q4 		$3.23K Hold
300
– – ﹤0.01% 2486
2023
Q3 		$2.15K Buy
+300
New +$2.99K ﹤0.01% 2514

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Global Retirement Partners's RXRX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Recursion Pharmaceuticals (RXRX) in Q2 2026: 70,100 shares worth $257K. The stake represents ﹤0.01% of the portfolio and ranks #1422 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in RXRX as recently as Q4 2025.

Global Retirement Partners first reported a position in RXRX in Q3 2023 and has held it in 10 quarters since. 342 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Global Retirement Partners held 70,100 shares of Recursion Pharmaceuticals worth $257K as of Q2 2026.
  • Recursion Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #1422 holding.
  • Global Retirement Partners first reported a position in Recursion Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
  • 342 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.